Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution - A role for immunotherapy. | Front Immunol | 2022 | 36032085 | PubTator, text mining | PubMed |
| ACPA-negative rheumatoid arthritis: From immune mechanisms to clinical translation. | EBioMedicine | 2022 | 36027873 | PubTator, text mining | PubMed |
| Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells. | Nutrients | 2022 | 36014919 | PubTator, text mining | PubMed |
| HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct. | J Clin Med | 2022 | 36013065 | PubTator, text mining | PubMed |
| Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery. | Int J Mol Sci | 2022 | 36012423 | PubTator, text mining | PubMed |
| Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology. | Biomedicines | 2022 | 36009573 | PubTator, text mining | PubMed |
| The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing. | Signal Transduct Target Ther | 2022 | 36008393 | PubTator, text mining | PubMed |
| Vascular Implications of COVID-19: Role of Radiological Imaging, Artificial Intelligence, and Tissue Characterization: A Special Report. | J Cardiovasc Dev Dis | 2022 | 36005433 | PubTator, text mining | PubMed |
| PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer. | Front Immunol | 2022 | 36003382 | PubTator, text mining | PubMed |
| Saliva as an alternative specimen to nasopharyngeal swabs for COVID-19 diagnosis: Review. | Access Microbiol | 2022 | 36003360 | PubTator, text mining | PubMed |
| Single cell transcriptomic analysis of the immune cell compartment in the human small intestine and in Celiac disease. | Nat Commun | 2022 | 35995787 | PubTator, text mining | PubMed |
| Consequences of COVID-19 on the cardiovascular and renal systems. | Sleep Med | 2022 | 35994936 | PubTator, text mining | PubMed |
| Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways. | Inflammopharmacology | 2022 | 35994216 | PubTator, text mining | PubMed |
| Synthetically recoded virus sCPD9 - A tool to accelerate SARS-CoV-2 research under biosafety level 2 conditions. | Comput Struct Biotechnol J | 2022 | 35992535 | PubTator, text mining | PubMed |
| Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. | Nat Cardiovasc Res | 2022 | 35990517 | PubTator, text mining | PubMed |
| Single-cell atlas of diverse immune populations in the advanced biliary tract cancer microenvironment. | NPJ Precis Oncol | 2022 | 35982235 | PubTator, text mining | PubMed |
| Heterogeneity of circulating CD4+CD8+ double-positive T cells characterized by scRNA-seq analysis and trajectory inference. | Sci Rep | 2022 | 35982155 | PubTator, text mining | PubMed |
| Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level. | Blood Adv | 2022 | 35977111 | PubTator, text mining | PubMed |
| Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy. | Front Immunol | 2022 | 35967414 | PubTator, text mining | PubMed |
| A single-cell map of vascular and tissue lymphocytes identifies proliferative TCF-1+ human innate lymphoid cells. | Front Immunol | 2022 | 35967297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=56